Keyphrases
Antioxidant Activity
66%
Biosamples
33%
Cardiovascular Disease
66%
Cardiovascular Risk
100%
Closeout
33%
Conventional Treatment
33%
Diabetes Complications
100%
Diabetes Control
100%
Diabetes Epidemiology
100%
Diabetes Intervention
100%
Disease Case
33%
F2-isoprostanes
66%
Glycemic Control
33%
Hyperglycemia
33%
Intensive Care Medicine
33%
Low Risk
33%
Myeloperoxidase
66%
No Significant Difference
33%
Oxidative Markers
66%
Oxidative Stress
100%
Oxidative Stress Markers
66%
Paraoxonase 1 (PON1)
33%
Paraoxonase-1 Activity
66%
Prostaglandin F2α
100%
Sample Selection
33%
Selection Probability
33%
Treatment Group
33%
Type 1 Diabetes Mellitus (T1DM)
100%
Vascular Complications
66%
Medicine and Dentistry
Antioxidant Capacity
50%
Aryldialkylphosphatase
75%
Biological Marker
50%
Cardiovascular Disease
100%
Cardiovascular Risk
100%
Diabetes Control and Complications Trial
100%
Epidemiology of Diabetes
100%
Glycemic Control
25%
Hyperglycemia
25%
Insulin Dependent Diabetes Mellitus
100%
Isoprostane Derivative
50%
Metabolite
25%
Microvascular Complication
25%
Myeloperoxidase
50%
Oxidative Stress
100%
Patient with Type 1 Diabetes
25%
Prostaglandin F2
75%
Treatment Group
25%
Urinary System
25%
Biochemistry, Genetics and Molecular Biology
Antioxidant Activity
50%
Aryldialkylphosphatase
75%
Blood Plasma
25%
Glycemic Control
25%
Hyperglycemia
25%
Isoprostane
50%
Metabolite
25%
Myeloperoxidase
50%
Oxidative Stress
100%
Paraoxonase
75%
Prostaglandin
75%